{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=MYOPATHY&page=4", "query": { "condition": "MYOPATHY", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 1992, "total_pages": 200, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=MYOPATHY&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=MYOPATHY&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T00:10:43.122Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07398417", "title": "Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "AXS-14 (Esreboxetine)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 620, "start_date": "2026-01-14", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-09-04", "last_synced_at": "2026-10-31T00:10:43.122Z", "location_count": 53, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Tucson, Arizona + 46 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07398417" }, { "nct_id": "NCT00673452", "title": "A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "duloxetine hydrochloride", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 530, "start_date": "2008-06", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2010-06-24", "last_synced_at": "2026-10-31T00:10:43.122Z", "location_count": 43, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Los Angeles, California + 40 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Cromwell", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00673452" }, { "nct_id": "NCT04575090", "title": "7 Tesla MRI Study in Patients With Statin Related Muscle Complaints", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Statin-related Muscle Pain", "Muscle Aches", "Muscle Weakness", "Muscle Cramp", "Muscle Stiffness" ], "interventions": [ { "name": "Simvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 8, "start_date": "2016-03-05", "completion_date": "2021-06-23", "has_results": true, "last_update_posted_date": "2022-10-31", "last_synced_at": "2026-10-31T00:10:43.122Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04575090" }, { "nct_id": "NCT00451074", "title": "Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Duchenne Muscular Dystrophy" ], "interventions": [ { "name": "Gentamicin infusions twice a week for six months", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nationwide Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "20 Years", "sex": "MALE", "summary": "5 Years to 20 Years · Male only" }, "enrollment_count": 12, "start_date": "2007-03", "completion_date": "2009-07", "has_results": false, "last_update_posted_date": "2012-03-23", "last_synced_at": "2026-10-31T00:10:43.122Z", "location_count": 3, "location_summary": "Scottsdale, Arizona • Kansas City, Kansas • Columbus, Ohio", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00451074" }, { "nct_id": "NCT04886518", "title": "Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myotonic Dystrophy 1", "Excessive Daytime Sleepiness" ], "interventions": [ { "name": "Pitolisant Oral Tablet", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Harmony Biosciences Management, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 30, "start_date": "2021-06-28", "completion_date": "2024-10-31", "has_results": true, "last_update_posted_date": "2026-09-04", "last_synced_at": "2026-10-31T00:10:43.122Z", "location_count": 11, "location_summary": "Irvine, California • Aurora, Colorado • Tampa, Florida + 8 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04886518" }, { "nct_id": "NCT05812209", "title": "Stellate Ganglion Block to Treat Long COVID 19 Case Series", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Long COVID", "Long Covid19", "Post-COVID-19 Syndrome", "Post Acute COVID-19 Syndrome", "Dysautonomia", "Anosmia", "Dysgeusia", "Brain Fog", "Muscle Pain", "Shortness of Breath", "Dizziness", "Fatigue Post Viral", "Cough", "Menstrual Cycle Abnormal", "Pain" ], "interventions": [ { "name": "Stellate Ganglion Block", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Metamorphosis LTD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 41, "start_date": "2022-09-01", "completion_date": "2022-12-31", "has_results": false, "last_update_posted_date": "2023-04-13", "last_synced_at": "2026-10-31T00:10:43.122Z", "location_count": 1, "location_summary": "Cañon City, Colorado", "locations": [ { "city": "Cañon City", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05812209" }, { "nct_id": "NCT00222690", "title": "Living With Fibromyalgia: Triggers,Subgroups, and a Cognitive-Behavioral and Interactive Technology-Based Intervention", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Fibromyalgia" ], "interventions": [], "intervention_types": [], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 30, "start_date": "2005-06", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2006-05-29", "last_synced_at": "2026-10-31T00:10:43.122Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00222690" }, { "nct_id": "NCT00178646", "title": "Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Stroke", "Brain Injuries", "Spasticity" ], "interventions": [ { "name": "Botox", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 33, "start_date": "2002-01", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2021-01-22", "last_synced_at": "2026-10-31T00:10:43.122Z", "location_count": 2, "location_summary": "West Orange, New Jersey • Houston, Texas", "locations": [ { "city": "West Orange", "state": "New Jersey" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00178646" }, { "nct_id": "NCT03196960", "title": "Effects of Mobility Dose in Surgical Intensive Care Unit Patients", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sarcopenia", "Muscle Weakness", "Critical Illness" ], "interventions": [], "intervention_types": [], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2017-05-22", "completion_date": "2018-12", "has_results": false, "last_update_posted_date": "2018-09-06", "last_synced_at": "2026-10-31T00:10:43.122Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03196960" }, { "nct_id": "NCT06192927", "title": "Efficacy and Safety of TenoMiR in Lateral Epicondylitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Tennis Elbow" ], "interventions": [ { "name": "TenoMiR", "type": "DRUG" }, { "name": "0.9% Sodium Chloride Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Causeway Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 123, "start_date": "2024-04-10", "completion_date": "2025-06-12", "has_results": false, "last_update_posted_date": "2025-08-01", "last_synced_at": "2026-10-31T00:10:43.122Z", "location_count": 3, "location_summary": "Redwood City, California • New York, New York", "locations": [ { "city": "Redwood City", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06192927" } ] }